Clinical Trials Logo

Hyperopia clinical trials

View clinical trials related to Hyperopia.

Filter by:

NCT ID: NCT05689567 Active, not recruiting - Myopia Clinical Trials

Focus-out Glasses on Emmetropization in Chinese Children

Start date: March 23, 2023
Phase: N/A
Study type: Interventional

The purpose of this study is to characterize the effects of peripheral focous-out glasses on emmetropization in non-myopic Chinese Children Aged 6-8 Years.This is a prospective, parallel-controlled randomized trial.

NCT ID: NCT05660577 Completed - Clinical trials for Myopia and Hyperopia and Presbyopia

Evaluation of Product Performance of a New Silicone Hydrogel Multifocal Contact Lens

Start date: November 7, 2022
Phase: N/A
Study type: Interventional

The objective of this study is to evaluate the product performance of a new silicone hydrogel daily disposable multifocal contact lens, the Bausch + Lomb (kalifilcon A) Daily Disposable Multifocal Contact Lens, when worn by current soft contact lens wearers on a daily disposable wear basis

NCT ID: NCT05656885 Completed - Myopia Clinical Trials

Clinical Evaluation of Two Frequent Replacement Soft Spherical Contact Lenses

Start date: September 27, 2022
Phase: N/A
Study type: Interventional

This was a single-blind (participant masked), interventional, prospective, direct refit, bilateral wear short-term fitting study.

NCT ID: NCT05588362 Not yet recruiting - Myopia Clinical Trials

Access to EyeGlasses for School-aged Children

ATEG
Start date: February 1, 2023
Phase: N/A
Study type: Interventional

Uncorrected refractive error is a leading cause of visual impairment in children and can impact vision, quality of life, and academic performance. Despite Boston Children's Hospital serving patients from a wide range of socioeconomic backgrounds, there are health disparities in access to eyeglasses as a consequence of patients' health insurance. The investigators will examine whether the use of an in-clinic app for 3-D printed glasses reduces disparities in access to eyeglasses for our patients on Medicaid. The intervention will address social determinants of health and improve pediatric health outcomes namely, how and when children having publicly funded health insurance receive eyeglasses. The short-term objectives are (1) to compare the time to receive glasses between publicly funded MassHealth eyeglasses and an in-clinic order of 3D printed glasses (2) to evaluate compliance with glasses wear in these two groups, and (3) to evaluate visual function and quality-of-life outcomes in these two groups. This prospective randomized control study will evaluate barriers to accessing eyeglasses in school-aged children. The investigators will recruit children enrolled in MassHealth and randomize them into two cohorts: (1) the control group will receive MassHealth glasses as per standard of care, through an optical shop of their choosing, or (2) the intervention group will use an app for immediately ordering glasses (paid for by the study) in clinic following their appointment. The investigators will evaluate the time needed to receive eyeglasses, compliance with glasses wear, quality of life, and visual outcomes between the cohorts at one-, three-, and six-month intervals. Through this project, the investigators will not only evaluate, quantify, and bring awareness to disparities in our patient population, but will also look toward finding a solution through the use of a novel application that addresses many of the barriers faced by patients insured through Medicaid.

NCT ID: NCT05538182 Completed - Hyperopia Clinical Trials

Zimbabwe Eyecare And Learning(ZEAL):Formative Research on Hyperopia and Educational Outcomes in Primary School Children

ZEAL
Start date: September 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to determine whether uncorrected or corrected long-sightedness (hyperopia) has an impact on reading skills, in Grade 2 or Grade 4 school-aged children from Mashonaland Central province of Zimbabwe, compared to age-, gender- and school-matched children with no refractive error (emmetropia), measured by the Happy Readers V4 reading tool over six months.

NCT ID: NCT05486741 Not yet recruiting - Clinical trials for OCT Study RNFL and Macular Thickness

Retinal Nerve Fiber Layer Thickness and Macular Thickness in Myopia, Hyperopia and Emmetropia : An OCT Study

Start date: November 2022
Phase:
Study type: Observational

The purpose of this study is to investigate the variability of RNFL and macular thickness between myopia , hyper metropia and emmetropia

NCT ID: NCT05477875 Recruiting - Myopia Clinical Trials

Cannabinoid vs Opioid for Photorefractive Keratectomy Pain Control

Start date: February 1, 2024
Phase: Phase 2
Study type: Interventional

Photorefractive Keratectomy (PRK) is a commonly performed corneal refractive surgery but has significant post-operative pain. Pain medications after PRK are typically opioid-acetaminophen combinations. Alternatives to opioid medication are worth consideration. Patients will receive PRK in each eye sequentially, using the cannabinoid or codeine/acetaminophen for one eye and the other treatment for the fellow eye two weeks later.

NCT ID: NCT05264623 Recruiting - Hyperopia Clinical Trials

Safety and Effectiveness of the TENEO 317 Model 2 (1.28 US) Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Hyperopia With or Without Astigmatism

Start date: November 15, 2022
Phase: N/A
Study type: Interventional

This will be a multicenter, prospective, open label, non-randomized, single arm 12 month study, evaluating the safety and effectiveness of the TECHNOLAS TENEO 317 Model 2 (Software version "1.28 US") excimer laser when used in LASIK surgery to treat hyperopia with or without hyperopic astigmatism. Both eyes of a subject may be enrolled so long as both eyes meet all inclusion/exclusion requirements. Analysis of the primary effectiveness endpoint will be completed at refractive stability.

NCT ID: NCT05261685 Completed - Moderate Hyperopia Clinical Trials

Single-step Transepithelial PRK for Hyperopia

Start date: December 1, 2019
Phase: N/A
Study type: Interventional

Hyperopia is one of the commonest refractive errors encountered in ophthalmology practice. Laser in situ keratomileusis (LASIK) has been widely used to correct hyperopia especially with the advent of femtosecond laser technology allowing larger flap creation suitable for peripheral hyperopic ablations with resultant predictable, effective, and safe refractive outcomes. However, the encountered LASIK flap complications encouraged many surgeons to assess efficiency and safety of surface ablation techniques such as photorefractive keratectomy (PRK) to correct hyperopia.

NCT ID: NCT05254587 Completed - Cataract Clinical Trials

Accuracy of IOLMASTER 700 Total Keratometry (TK)

Start date: February 8, 2022
Phase:
Study type: Observational

This is a multicenter study to compare the accuracy of IOL calculations in post-laser vision corrected eyes that are about to undergo or have undergone cataract surgery.